109 related articles for article (PubMed ID: 3115632)
1. Effect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjects.
Valcavi R; Dieguez C; Azzarito C; Edwards CA; Dotti C; Page MD; Portioli I; Scanlon MF
Clin Endocrinol (Oxf); 1987 Apr; 26(4):453-8. PubMed ID: 3115632
[TBL] [Abstract][Full Text] [Related]
2. Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone.
Valcavi R; Zini M; Maestroni GJ; Conti A; Portioli I
Clin Endocrinol (Oxf); 1993 Aug; 39(2):193-9. PubMed ID: 8370132
[TBL] [Abstract][Full Text] [Related]
3. Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration.
Sartorio A; Spada A; Bochicchio D; Atterrato A; Morabito F; Faglia G
Neuroendocrinology; 1986; 44(4):470-4. PubMed ID: 3102991
[TBL] [Abstract][Full Text] [Related]
4. Effects of active immunization against somatostatin on serum growth hormone concentration in growing pigs: influence of fasting and repetitive somatocrinin injections.
Dubreuil P; Pelletier G; Petitclerc D; Lapierre H; Gaudreau P; Brazeau P
Endocrinology; 1989 Sep; 125(3):1378-84. PubMed ID: 2569391
[TBL] [Abstract][Full Text] [Related]
5. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin.
Lanzi R; Tannenbaum GS
Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term GH-releasing factor administration on patterns of GH and LH secretion in growing female buffaloes (Bubalus bubalis).
Mondal M; Prakash BS
Reproduction; 2004 Jan; 127(1):45-55. PubMed ID: 15056769
[TBL] [Abstract][Full Text] [Related]
8. Hormone ontogeny in the ovine fetus and neonatal lamb. XX. Effect of age, breeding season, and twinning on the growth hormone (GH) response to GH-releasing factor: evidence for a homeostatic role of fetal GH.
de Zegher F; Styne DM; Daaboul J; Bettendorf M; Kaplan SL; Grumbach MM
Endocrinology; 1989 Jan; 124(1):124-8. PubMed ID: 2491803
[TBL] [Abstract][Full Text] [Related]
9. Interaction between growth hormone releasing factor (GRF) and somatostatin analogue (SMS 201-995) in normal subjects.
Losa M; Müller OA; Sobieszczyk S; von Werder K
Clin Endocrinol (Oxf); 1985 Dec; 23(6):715-20. PubMed ID: 2869845
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with somatostatin analog SMS 201-995 potentiates growth hormone (GH) responsiveness to GH-releasing factor in short children.
Dickerman Z; Guyda H; Tannenbaum GS
J Clin Endocrinol Metab; 1993 Sep; 77(3):652-7. PubMed ID: 8257527
[TBL] [Abstract][Full Text] [Related]
11. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
[TBL] [Abstract][Full Text] [Related]
12. Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.
Rosenthal SM; Hulse JA; Kaplan SL; Grumbach MM
J Clin Invest; 1986 Jan; 77(1):176-80. PubMed ID: 3080472
[TBL] [Abstract][Full Text] [Related]
13. Effects of GRF(1-40) and domperidone on GH secretion in normal man.
Giusti M; Mazzocchi G; Sessarego P; Mignone D; Lomeo A; Monachesi M; Giordano G
Clin Endocrinol (Oxf); 1984 Oct; 21(4):339-43. PubMed ID: 6439434
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
Van Vliet G; Bosson D; Robyn C; Craen M; Malvaux P; Vanderschueren-Lodeweyckx M; Wolter R
Horm Res; 1985; 22(1-2):32-45. PubMed ID: 3928475
[TBL] [Abstract][Full Text] [Related]
15. Hormone ontogeny in the ovine fetus and neonate. XXII. The effect of somatostatin on the growth hormone (GH) response to GH-releasing factor.
de Zegher F; Daaboul J; Grumbach MM; Kaplan SL
Endocrinology; 1989 Mar; 124(3):1114-7. PubMed ID: 2563681
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) secretion in the dwarf rat: release, clearance and responsiveness to GH-releasing factor and somatostatin.
Carmignac DF; Robinson IC
J Endocrinol; 1990 Oct; 127(1):69-75. PubMed ID: 1983310
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
[TBL] [Abstract][Full Text] [Related]
18. Diminished pituitary responsiveness to growth hormone-releasing factor in aging male rats.
Ceda GP; Valenti G; Butturini U; Hoffman AR
Endocrinology; 1986 May; 118(5):2109-14. PubMed ID: 3009151
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
Tancer ME; Stein MB; Uhde TW
Psychoneuroendocrinology; 1990; 15(4):253-9. PubMed ID: 2087535
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of growth hormone releasing factor and insulin hypoglycaemia on growth hormone release in man.
Page MD; Koppeschaar HP; Edwards CA; Dieguez C; Scanlon MF
Clin Endocrinol (Oxf); 1987 May; 26(5):589-95. PubMed ID: 3117447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
